Clinical trial
Effects of Ocrevus in Relapsing Multiple Sclerosis
NCT04387734
Study timeline
Study start (actual)2021-02-05Date precision: day
Registry last updated2026-06-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Multiple Sclerosisunresolved
Interventions
OcrelizumabDRUG · verified · RxNorm: ocrelizumab
PlatformDRUG
Sponsors & collaborators
Georgia State Universitylead sponsor
Multiple Sclerosis Center of Atlantacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04387734 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.